المؤلفون: Lennep, J.E.R. van, Tokgözoglu, L.S., Badimon, L., Dumanski, S.M., Gulati, M., Hess, C.N., Holven, K.B., Kavousi, M., Kayikçioglu, M., Lutgens, E., Michos, E.D., Prescott, E., Stock, J.K., Tybjaerg-Hansen, A., Wermer, M.J.H., Benn, M.

المصدر: European Heart Journal

مصطلحات موضوعية: Women, Atherosclerotic cardiovascular disease, Sex-specific risk, Lipids, Cholesterol, Triglycerides, Lipoprotein(a)

وصف الملف: application/pdf

العلاقة: https://academic.oup.com/eurheartj/article/44/39/4157/7249105Test; lumc-id: 185191769; https://hdl.handle.net/1887/3714029Test

الإتاحة: https://doi.org/10.1093/eurheartj/ehad472Test
https://hdl.handle.net/1887/3714029Test
https://academic.oup.com/eurheartj/article/44/39/4157/7249105Test

المؤلفون: Fruchart, J.C., Santos, R.D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P.J., Ceska, R., Corsini, A., Després, J.P., Duriez, P., Eckel, R.H., Ezhov, M.V., Farnier, M., Ginsberg, H.N., Hermans, M.P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W., Krempf, M., Lim, S., Lorenzatti, A.J., McPherson, R., Nuñez-Cortes, J.M., Nordestgaard, B.G., Ogawa, H., Packard, C.J., Plutzky, J., Ponte-Negretti, C.I., Pradhan, A., Ray, K.K., Reiner, Ž., Ridker, P.M., Ruscica, M., Sadikot, S., Shimano, H., Sritara, P., Stock, J.K., Su, T.C., Susekov, A.V., Tartar, A., Taskinen, M.R., Tenenbaum, A., Tokgözoğlu, L.S., Tomlinson, B., Tybjærg-Hansen, A., Valensi, P., Vrablík, M., Wahli, W., Watts, G.F., Yamashita, S., Yokote, K., Zambon, A., Libby, P.

المصدر: Cardiovascular diabetology, vol. 18, no. 1, pp. 71

مصطلحات موضوعية: Animals, Benzoxazoles/adverse effects, Benzoxazoles/therapeutic use, Biomarkers/blood, Butyrates/adverse effects, Butyrates/therapeutic use, Cardiovascular Diseases/blood, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/prevention & control, Consensus, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy, Humans, Hypolipidemic Agents/adverse effects, Hypolipidemic Agents/therapeutic use, Lipids/blood, Molecular Targeted Therapy, PPAR alpha/agonists, PPAR alpha/metabolism, Patient Safety, Risk Assessment, Risk Factors, Signal Transduction, Treatment Outcome, Atherogenic dyslipidemia, Diabetes, Inflammation, PROMINENT, Pemafibrate (K-877)

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31164165; info:eu-repo/semantics/altIdentifier/eissn/1475-2840; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A62033B5071E0; https://serval.unil.ch/notice/serval:BIB_A62033B5071ETest; urn:issn:1475-2840; https://serval.unil.ch/resource/serval:BIB_A62033B5071E.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A62033B5071E0Test

الإتاحة: https://doi.org/10.1186/s12933-019-0864-7Test
https://serval.unil.ch/notice/serval:BIB_A62033B5071ETest
https://serval.unil.ch/resource/serval:BIB_A62033B5071E.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A62033B5071E0Test

المؤلفون: Fruchart, J.C., Santos, R.D., Yamashita, S., Libby, P.

المساهمون: International Atherosclerosis Society/R3i Foundation Consensus Panel, Fruchart, J.C., Santos, R.D., Yamashita, S., Aikawa, M., Libby, P., Plutzky, J., Pradhan, A., Ridker, P., Aguilar-Salinas, C., Al Rasadi, K., Amarenco, P., Barter, P.J., Ceska, R., Corsini, A., Ruscica, M., Després, J.P., Duriez, P., Eckel, R.H., Ezhov, M.V., Farnier, M., Ginsberg, H.N., Hermans, M.P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W., Krempf, M., Lim, S., Lorenzatti, A.J., McPherson, R., Nuñez-Cortes, J.M., Nordestgaard, B.G., Ogawa, H., Packard, C.J., Ponte-Negretti, C.I., Reiner, Ž., Sadikot, S., Shimano, H., Sritara, P., Stock, J.K., Su, T.C., Susekov, A.V., Tartar, A., Taskinen, M.R., Tenenbaum, A., Tokgözoğlu, L.S., Tomlinson, B., Tybjærg-Hansen, A., Valensi, P., Vrablík, M., Wahli, W., Watts, G.F., Yokote, K., Zambon, A.

المصدر: Diabetes & metabolic syndrome, vol. 13, no. 4, pp. 2723-2725

مصطلحات موضوعية: Diabetes Mellitus, Type 2/complications, Diabetic Angiopathies/drug therapy, Diabetic Angiopathies/etiology, Diabetic Angiopathies/metabolism, Humans, PPAR alpha/agonists, PPAR alpha/antagonists & inhibitors, Prognosis

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31405699; info:eu-repo/semantics/altIdentifier/eissn/1878-0334; https://serval.unil.ch/notice/serval:BIB_D94E3A861A64Test; urn:issn:1871-4021

الإتاحة: https://doi.org/10.1016/j.dsx.2019.05.034Test
https://serval.unil.ch/notice/serval:BIB_D94E3A861A64Test